D-Aspartic Acid

Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for D-Aspartic Acid.

D-Aspartic acid acts as a physiological NMDA receptor agonist and accumulates in the adenohypophysis and testes, where it upregulates the synthesis of testosterone by increasing the expression of steroidogenic acute regulatory protein and stimulating the release of luteinizing hormone.

Verified Molecular Profiling (NIH PubChem)

PubChem CID

439197

Molecular Weight

309.27 g/mol

XLogP3 (Lipophilicity)

-3.5

IUPAC Name

(4S,5R,6R)-5-acetamido-2,4-dihydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid

Pharmacokinetic Synergies & Enhancers

Proven Synergy Pairings

Zinc for supporting steroidogenesis and preventing aromatization
Vitamin D3 for optimizing androgen receptor sensitivity and total testosterone production

Biological Formulation Enhancers

Piperine for increasing intestinal permeability and metabolic stability
Liposomal encapsulation for bypassing first-pass metabolism and improving cellular uptake in the hypothalamus

Delivery System Constraints & Modeling

Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for D-Aspartic Acid across standard consumer modalities.

💊 Standard Capsules

The high hygroscopicity of D-aspartic acid can lead to clumping and reduced flowability during high-speed encapsulation, requiring specific glidants like silicon dioxide.

🍬 Gummy & Pectin Formats

The acidic nature of D-aspartic acid can interfere with pectin gelation kinetics and lower the final pH, potentially leading to syneresis or a soft, unstable texture.

🔬 Thin-Film Oral Strips

The high therapeutic dose required for efficacy exceeds the typical 50-100mg payload capacity of thin-film polymer matrices, making this format impractical for standard dosing.

For Brand Founders

Formulate with D-Aspartic Acid

Ready to launch a product featuring D-Aspartic Acid? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.

Build Science-Backed Formulation

Efficacy Evidence

Maximize D-Aspartic Acid Bioavailability

Need absolute proof that your D-Aspartic Acid extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.

Simulate Bioavailability

For R&D Labs & CDMOs

D-Aspartic Acid Degradation Testing

Is your D-Aspartic Acid payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.

Model Active Degradation